Metabolomic Study in Huntington's Disease (METABO-HD)
NCT03296176 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2017-11-01
Summary
The purpose of this project is to study Huntington's disease by metabolomic approach.
Conditions
- Huntington Disease
Interventions
- BIOLOGICAL
-
blood sample
blood sample for metabolome analyse
Sponsors & Collaborators
-
University Hospital, Angers
lead OTHER_GOV
Principal Investigators
-
Christophe Verny, PU-PH · University Hospital, Angers
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-09
- Primary Completion
- 2019-09-30
- Completion
- 2019-09-30
Countries
- France
Study Locations
More Related Trials
-
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
NCT00670709 ·Status: COMPLETED
-
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
NCT05360082 ·Status: RECRUITING ·Phase: NA
-
Is Caffeine an Environmental Modifier in Huntington's Disease?
NCT03034122 ·Status: COMPLETED
-
Brain Function and EEG
NCT05003076 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Precision Functional Brain Mapping in Psilocybin
NCT04501653 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB
NCT00527579 ·Status: COMPLETED ·Phase: PHASE1
-
Clinicopathological MRI and CSF Correlates in Huntington's Disease.
NCT05534139 ·Status: UNKNOWN
-
Effects of Drugs on Cerebral Blood Flow in Patients With Mood Disorders
NCT00001478 ·Status: COMPLETED
-
Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease
NCT01860339 ·Status: COMPLETED
-
Huntington's Disease and Pain
NCT06693466 ·Status: NOT_YET_RECRUITING
-
PET Imaging of Dopamine in Healthy Study Participants
NCT00062946 ·Status: COMPLETED ·Phase: PHASE2
-
Diurnal Variations of Brain Metabolite Concentrations in 1H-MRS
NCT03497832 ·Status: COMPLETED ·Phase: NA
-
Epilepsy in Alzheimer's Disease: Effect on Disease Progression
NCT04131491 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a
NCT01461083 ·Status: COMPLETED ·Phase: PHASE1
-
Longitudinal Neural Fingerprinting of Opioid-use Trajectories
NCT06207162 ·Status: RECRUITING ·Phase: NA
-
Imaging of Brain Receptors Using (11C)mGlu1
NCT01420952 ·Status: TERMINATED ·Phase: PHASE1
-
Exploration of Differences in Metabolite Concentrations by NMR Spectroscopy in the Ventral Striatum, Anterior Cingulate Cortex and Prefrontal Cortex in Euthymic Patients With Unipolar and Bipolar Type II Mood Disorders, as Well as in Healthy Subjects
NCT05650788 ·Status: COMPLETED ·Phase: NA
-
Executive Function Disorders and Anxio-depressive Symptomatology in Children and Adolescents With Mitochondrial Pathologies
NCT03832218 ·Status: COMPLETED ·Phase: NA
-
PET Imaging of Brain mGluR1 Receptors Using [18F]FIMX
NCT02230592 ·Status: COMPLETED
-
Individuals Patterns of Disclosure About Huntington s Disease (HD) and the Association With Adaptation to HD
NCT00491842 ·Status: COMPLETED
-
Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF)
NCT06008704 ·Status: RECRUITING ·Phase: NA
-
To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers
NCT01173757 ·Status: COMPLETED ·Phase: PHASE1
-
PET Imaging of Brain 5-HT(1A) Receptors Using [(11)C](-)-RWAY
NCT00263523 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating the Mechanisms of Mindfulness-based Cognitive Therapy (MBCT)
NCT02226042 ·Status: COMPLETED ·Phase: NA
-
Serotonin Receptors in Seizure Disorders
NCT00001932 ·Status: COMPLETED